MaxCyte, Inc. announced today a strategic collaboration with leading academic research institution, Washington University in St. Louis (“Washington University”) to…
Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, "Astellas") and Immunomic Therapeutics, Inc. (Founder & CEO: William Hearl, Ph.D., "Immunomic…